SAN FRANCISCO — Attorneys from Wilson Sonsini Goodrich & Rosati advised Pacific Biosciences of California Inc. in an initial public offering, which raised $200 million. It sold 12.5 million shares at the midpoint of its $15 to $17 price range.
And it’s one more sign that the U.S. market for IPOs is stabilizing. The Menlo Park-based genetic-sequencing company has created an instrument platform that lets scientists observe nucleotides being added to DNA in real time.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
